BRCA1 and neoplasm: These results demonstrated that estrogen activates EMT in a subset of Brca1-deficient tumor cells that have not undergone EMT, and further indicated that estrogen promotes EMT in ER-negative Brca1-deficient tumor cells independent of ER.